Drug reaction with eosinophilia and systemic symptoms in a paediatric population: Interest of skin tests

Contact Dermatitis. 2023 Dec;89(6):488-495. doi: 10.1111/cod.14416. Epub 2023 Sep 20.

Abstract

Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe adverse drug reaction. It is uncommon in the paediatric population and can be difficult to diagnose as its initial symptoms may mimic a viral infection.

Objective: To analyse the features of paediatric DRESS and to evaluate the interest of skin tests in identifying the causative drugs.

Methods: It is a retrospective analysis (2004-2021) of DRESS cases diagnosed in paediatric patients. The DRESS diagnosis was defined using the RegiSCAR scoring. The skin tests were performed according to the ENDA recommendations.

Results: We included 19 cases of DRESS occurred in 18 patients. Common clinical symptoms were exanthema and fever in 94.7% of cases each. The most commonly affected organ was the liver (84.2%). Among the implicated drugs, 16 were tested and skin tests were positive in 75%. To assess cross-reactivity and co-sensitization, skin tests with related and/or co-administered drugs were performed in eight patients. Among them, only one child had positive results.

Conclusion: Early diagnosis of DRESS and discontinuation of the incriminated drug might reduce the incidence of mortality in the paediatric population. Skin tests could be a safe and useful tool to identify the causative drug and assess cross-reactivity.

Keywords: DRESS; children; drug reaction with eosinophilia and systemic symptoms; paediatric; skin tests.

MeSH terms

  • Child
  • Dermatitis, Allergic Contact*
  • Drug Hypersensitivity Syndrome* / diagnosis
  • Eosinophilia*
  • Humans
  • Retrospective Studies
  • Skin Tests